David Castel

Villejuif, 94805, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 64 publications

H3K27ME3 loss in diffuse midline gliomas lacking H3K27M or EZHIP expressions, a potential diagnostic pitfall!

H3K27ME3 loss in diffuse midline gliomas lacking H3K27M or EZHIP expressions, a potential diagnostic pitfall!

Journal: Acta neuropathologica
Published: December 23, 2025

Usefulness OF SOX10 immunohistochemistry for subtyping diffuse midline gliomas EGFR-altered.

Usefulness OF SOX10 immunohistochemistry for subtyping diffuse midline gliomas EGFR-altered.

Journal: Acta neuropathologica communications
Published: November 15, 2025

Author Correction: Reciprocal signalling by Notch-Collagen V-CALCR retains muscle stem cells in their niche.

Author Correction: Reciprocal signalling by Notch-Collagen V-CALCR retains muscle stem cells in their niche.

Journal: Nature
Published: October 31, 2025

Phase I/II Study of the PARP Inhibitor Olaparib and Irinotecan in Children and Young Adults with Recurrent/Refractory Malignancies: Arm D of the AcSé-ESMART Trial.

Phase I/II Study of the PARP Inhibitor Olaparib and Irinotecan in Children and Young Adults with Recurrent/Refractory Malignancies: Arm D of the AcSé-ESMART Trial.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 08, 2025

Targeted therapies plus radiotherapy for diffuse intrinsic pontine glioma: the randomized phase 2 BIOMEDE trial.

Targeted therapies plus radiotherapy for diffuse intrinsic pontine glioma: the randomized phase 2 BIOMEDE trial.

Journal: Nature medicine
Published: October 02, 2025

Glioma oncogenesis in the Constitutional mismatch repair deficiency (CMMRD) syndrome.

Glioma oncogenesis in the Constitutional mismatch repair deficiency (CMMRD) syndrome.

Journal: Neuro-oncology advances
Published: September 05, 2024

Diffuse pediatric high-grade glioma of methylation-based RTK2A and RTK2B subclasses present distinct radiological and histomolecular features including Gliomatosis cerebri phenotype.

Diffuse pediatric high-grade glioma of methylation-based RTK2A and RTK2B subclasses present distinct radiological and histomolecular features including Gliomatosis cerebri phenotype.

Journal: Acta neuropathologica communications
Published: August 22, 2024

Gliomatosis cerebri in children: A poor prognostic phenotype of diffuse gliomas with a distinct molecular profile.

Gliomatosis cerebri in children: A poor prognostic phenotype of diffuse gliomas with a distinct molecular profile.

Journal: Neuro-oncology
Published: May 08, 2024

A non-midline unclassified glioneuronal tumor with H3K27M mutation enlarging the spectrum of CNS tumors H3K27ME3-altered.

A non-midline unclassified glioneuronal tumor with H3K27M mutation enlarging the spectrum of CNS tumors H3K27ME3-altered.

Journal: Journal of neuropathology and experimental neurology
Published: April 23, 2024

Atrx loss as a promising screening tool for the identification of diffuse midline glioma subtype, H3K27/MAPKinase co-altered.

Atrx loss as a promising screening tool for the identification of diffuse midline glioma subtype, H3K27/MAPKinase co-altered.

Journal: Acta neuropathologica communications
Published: March 29, 2024

"Hemispheric pilocytic astrocytoma" revisited: A comprehensive clinicopathological and molecular series emphasizing their overlap with other glioneuronal tumors.

"Hemispheric pilocytic astrocytoma" revisited: A comprehensive clinicopathological and molecular series emphasizing their overlap with other glioneuronal tumors.

Journal: Journal of neuropathology and experimental neurology
Published: January 18, 2024

Diffuse midline glioma invasion and metastasis rely on cell-autonomous signaling.

Diffuse midline glioma invasion and metastasis rely on cell-autonomous signaling.

Journal: Neuro-oncology
Published: September 13, 2023
Showing 1-12 of 64

Last Updated: 09/26/2026